381 related articles for article (PubMed ID: 33829508)
1. Group-2 Innate Lymphoid Cells Promote HCC Progression Through CXCL2-Neutrophil-Induced Immunosuppression.
Xu X; Ye L; Zhang Q; Shen H; Li S; Zhang X; Ye M; Liang T
Hepatology; 2021 Nov; 74(5):2526-2543. PubMed ID: 33829508
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
[TBL] [Abstract][Full Text] [Related]
3. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
[TBL] [Abstract][Full Text] [Related]
4. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
[TBL] [Abstract][Full Text] [Related]
5. Neutrophils: Driving inflammation during the development of hepatocellular carcinoma.
Chen H; Zhou XH; Li JR; Zheng TH; Yao FB; Gao B; Xue TC
Cancer Lett; 2021 Dec; 522():22-31. PubMed ID: 34517084
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma.
Xia Y; Brown ZJ; Huang H; Tsung A
Cancer Med; 2021 Sep; 10(18):6374-6383. PubMed ID: 34390203
[TBL] [Abstract][Full Text] [Related]
7. Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma.
Peng ZP; Jiang ZZ; Guo HF; Zhou MM; Huang YF; Ning WR; Huang JH; Zheng L; Wu Y
J Hepatol; 2020 Oct; 73(4):906-917. PubMed ID: 32407813
[TBL] [Abstract][Full Text] [Related]
8. Single-cell profiling of human CD127
He Y; Luo J; Zhang G; Jin Y; Wang N; Lu J; Li C; Guo X; Qin N; Dai J; Chen Y
Hepatology; 2022 Oct; 76(4):1013-1029. PubMed ID: 35243668
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma.
Ding J; Xu K; Zhang J; Lin B; Wang Y; Yin S; Xie H; Zhou L; Zheng S
BMB Rep; 2018 Dec; 51(12):630-635. PubMed ID: 30293547
[TBL] [Abstract][Full Text] [Related]
10. C-C chemokine hepatocellular carcinoma motif ligand 5-deficiency promotes hepatocellular carcinoma progression by affecting B cell recruitment.
Li X; Han QC; Yu C; Luo YC; Wang F; Sun XH; Gao YQ; Tan WF; Xia Q
J Dig Dis; 2021 Jul; 22(7):433-441. PubMed ID: 33978316
[TBL] [Abstract][Full Text] [Related]
11. NCR
Liu Y; Song Y; Lin D; Lei L; Mei Y; Jin Z; Gong H; Zhu Y; Hu B; Zhang Y; Zhao L; Teo HY; Qiu J; Jiang W; Dong C; Wu D; Huang Y; Liu H
EBioMedicine; 2019 Mar; 41():333-344. PubMed ID: 30827928
[TBL] [Abstract][Full Text] [Related]
12. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
[TBL] [Abstract][Full Text] [Related]
13. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma.
Wang Z; He L; Li W; Xu C; Zhang J; Wang D; Dou K; Zhuang R; Jin B; Zhang W; Hao Q; Zhang K; Zhang W; Wang S; Gao Y; Gu J; Shang L; Tan Z; Su H; Zhang Y; Zhang C; Li M
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34489334
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral γδ T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma.
Zhao N; Dang H; Ma L; Martin SP; Forgues M; Ylaya K; Hewitt SM; Wang XW
Hepatology; 2021 Mar; 73(3):1045-1060. PubMed ID: 32502310
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of IL-33 induces a population of circulating KLRG1
Guillerey C; Stannard K; Chen J; Krumeich S; Miles K; Nakamura K; Smith J; Yu Y; Ng S; Harjunpää H; Teng MW; Engwerda C; Belz GT; Smyth MJ
Immunol Cell Biol; 2021 Jan; 99(1):65-83. PubMed ID: 32748462
[TBL] [Abstract][Full Text] [Related]
16. ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure.
Schulz-Kuhnt A; Greif V; Hildner K; Knipfer L; Döbrönti M; Zirlik S; Fuchs F; Atreya R; Zundler S; López-Posadas R; Neufert C; Ramming A; Kiefer A; Grüneboom A; Strasser E; Wirtz S; Neurath MF; Atreya I
Front Immunol; 2020; 11():691. PubMed ID: 32457736
[TBL] [Abstract][Full Text] [Related]
17. ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8
Wan J; Wu Y; Huang L; Tian Y; Ji X; Abdelaziz MH; Cai W; Dineshkumar K; Lei Y; Yao S; Sun C; Su Z; Wang S; Xu H
Cancer Lett; 2021 Apr; 502():34-43. PubMed ID: 33429004
[TBL] [Abstract][Full Text] [Related]
18. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
[No Abstract] [Full Text] [Related]
19. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis.
Neumann K; Karimi K; Meiners J; Voetlause R; Steinmann S; Dammermann W; Lüth S; Asghari F; Wegscheid C; Horst AK; Tiegs G
J Immunol; 2017 Jan; 198(1):128-137. PubMed ID: 27872212
[TBL] [Abstract][Full Text] [Related]
20. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z
J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]